As adverse events , hyperglycemia and oral moniliasis were observed in the PS group ( n = 4 ) and in the NB groups ( n = 5 ) , respectively , and treatment change was required in 9 patients ( 2 patients in the PS group and 7 patients in the NB groups ) ( p = 0.57 ) .